Triamcinolone Injection in the Neck: Appropriateness and Guidelines

Indications for Triamcinolone Neck Injections

The British Journal of Dermatology recommends intralesional triamcinolone for patchy hair loss of limited extent, particularly in cosmetically sensitive areas 1, 3
The British Journal of Dermatology suggests that triamcinolone is most suitable for patients with fewer than five patches of hair loss, each less than 3 cm in diameter 2, 4
Success rates of up to 62% have been reported with monthly injections of triamcinolone acetonide for alopecia areata, according to the British Journal of Dermatology 2
The response to triamcinolone is better in localized alopecia compared to extensive hair loss, as reported by the British Journal of Dermatology 2, 5
The American College of Rheumatology is not mentioned, however, the Arthritis and Rheumatology journal suggests that triamcinolone injections may be used for inflammatory joint conditions affecting the neck 6

The British Journal of Dermatology recommends using triamcinolone acetonide 5-10 mg/mL for alopecia areata, with injections just beneath the dermis in the upper subcutis 1, 2
The British Journal of Dermatology suggests that 0.05-0.1 mL per injection site will produce a tuft of hair growth about 0.5 cm in diameter 1, 4
Traditional needle injection is the most common method of administration, according to the British Journal of Dermatology 1, 2
The British Journal of Dermatology also mentions that triamcinolone can be administered via needleless devices, such as Dermajet 2

The British Journal of Dermatology reports that hair regrowth occurs in 62-64% of treated sites with triamcinolone injections for alopecia areata 1, 2
The effects of triamcinolone typically last about 9 months, according to the British Journal of Dermatology 1, 2
The British Journal of Dermatology found that tufts of hair grew in 33 of 34 sites injected with triamcinolone hexacetonide and in 16 of 25 sites injected with triamcinolone acetonide 1

The British Journal of Dermatology warns that skin atrophy at the injection site is a consistent side effect, particularly with triamcinolone 2, 7

The British Journal of Dermatology recommends better outcomes in patients with limited, patchy hair loss rather than extensive hair loss 1, 2
The British Journal of Dermatology suggests considering alternative treatments for patients with extensive or long-standing hair loss 7
The British Journal of Dermatology advises monitoring for local skin atrophy and considering repeated injections for sustained effect 1, 2
If no response is seen after several treatments, the British Journal of Dermatology recommends considering alternative therapies 7